Collection
Respiratory syncytial virus
Respiratory Syncytial Virus (RSV) is a prevalent respiratory virus that can cause severe illness in people of all ages. The impact of the COVID-19 pandemic has led to a delayed RSV outbreak with a greater number of infected patients reported in numerous countries. Despite the high prevalence of RSV infections, there are currently limited treatment options and no effective vaccine. This highlights the urgency for continued efforts to better understand RSV and develop new strategies for its prevention and control. This collection invites submissions from researchers and practitioners in the field of RSV, including but not limited to epidemiology, surveillance, clinical management and diagnosis.
Articles (8 in this collection)
-
-
Pre-COVID-19-pandemic RSV epidemiology and clinical burden in pediatric primary care in Italy: a comparative analysis across two regions for the 2019/2020 season
Authors (first, second and last of 19)
-
Respiratory syncytial virus subtypes in children with bronchiolitis: does it correlate with clinical severity?
Authors (first, second and last of 7)
-
Clinical features and outcomes of influenza and RSV coinfections: a report from Canadian immunization research network serious outcomes surveillance network
Authors (first, second and last of 7)
-
Evaluation of antibody-based preventive alternatives for respiratory syncytial virus: a novel multi-criteria decision analysis framework and assessment of nirsevimab in Spain
Authors (first, second and last of 12)
-
Role of the cAMP-PKA-NF-κB pathway in Mucin1 over-expression in A549 cells during Respiratory syncytial virus infection
Authors (first, second and last of 8)
-
-
Impact of COVID-19 on the changing pattern of human orthopneumovirus (respiratory syncytial virus) infection in Iran
Authors (first, second and last of 11)
